Zenotech Laboratories Ltd.
BSE: 532039
₹44.08
₹0.08
(0.18%)
As on 12-Jun-2026IST
Market cap
₹269 Cr
Revenue (TTM)
₹44 Cr
P/E Ratio
--
P/B Ratio
2.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-1 Cr
-
ROE
6 %
-
ROCE
11.5 %
-
Industry P/E
34.68
-
EV/EBITDA
20.8
-
Debt to Equity
0
-
Book Value
₹15.6
-
EPS
₹-0.2
-
Face value
10
-
Shares outstanding
61,030,568
10 Years Aggregate
CFO
₹43.31 Cr
EBITDA
₹55.12 Cr
Net Profit
₹3.25 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zenotech Lab
| -4.6 | -4.4 | 2.9 | -30.3 | -5.8 | 0.9 | -0.7 |
|
BSE Healthcare
| 9.1 | 1.2 | 7.9 | 7.7 | 25.1 | 13.2 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Zenotech Lab
| -35.5 | 7.3 | 2.7 | 6.1 | 66.1 | 48.8 | -30.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zenotech Lab
|
44.1 | 269.0 | 43.6 | -1.1 | 4.8 | -1 | -- | 2.8 |
| 3,131.0 | 39,096.7 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 37 | 8.6 | |
| 8,249.5 | 20,609.8 | 2,275.6 | 187.5 | 10.3 | 22.9 | 109.9 | 23.6 | |
| 2,407.8 | 18,328.7 | 2,187.2 | 649.7 | 31.5 | 19 | 28.6 | 5.1 | |
| 1,728.3 | 10,570.9 | 1,196.4 | 149.4 | -- | 27.5 | 57.1 | 14.2 | |
| 1,404.6 | 19,439.6 | 3,129.4 | 647.4 | 26.9 | 18.1 | 31.4 | 5.0 | |
| 2,257.7 | 36,308.8 | 4,147.8 | 709.5 | 22.3 | 19.1 | 51.2 | 8.7 | |
| 4,509.2 | 20,631.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.6 | 4.9 | |
| 6,287.0 | 10,413.7 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31.9 | 19.9 | |
| 546.8 | 10,682.7 | 1,538.1 | 226.2 | 20.4 | 9 | 43.9 | 4.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Zenotech Lab
Zenotech Laboratories Limited operates as a pharmaceutical specialty generic injectables company in India. The company manufactures oncology, biotechnology, and general injectable products, such as granulocyte-colony stimulating factor (GCSF) and... granulocyte-macrophage colony-stimulating factor (GMCSF). Its injectable product portfolio primarily serves therapy areas, such as oncology and anesthesiology. The company was formerly known as Sunline Technologies Limited and changed its name to Zenotech Laboratories Limited in August 2004. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India. Read more
-
Incorporated
1989
-
Chairman
--
-
Managing Director
--
-
Group
Sun Pharma
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Zenotech Laboratories Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Zenotech Lab
What is the current share price of Zenotech Laboratories Ltd Today?
The share price of Zenotech Laboratories Ltd is ₹44.08 (BSE) as of 12-Jun-2026 IST. Zenotech Laboratories Ltd has given a return of -5.82% in the last 3 years.
What is the current PB & PE ratio of Zenotech Laboratories Ltd?
Since, TTM earnings of Zenotech Laboratories Ltd is negative, P/E ratio is not available.
The P/B ratio of Zenotech Laboratories Ltd is 2.83 times as on 12-Jun-2026, a 42 discount to its peers’ median range of 4.91 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
56.45
|
3.30
|
|
2024
|
43.47
|
3.98
|
|
2023
|
24.79
|
3.49
|
|
2022
|
13.86
|
4.35
|
|
2021
|
0.00
|
4.41
|
What is the 52 Week High and Low of Zenotech Laboratories Ltd?
The 52-week high and low of Zenotech Laboratories Ltd are Rs 67.00 and Rs 33.55 as of 13-Jun-2026.
What is the market cap of Zenotech Laboratories Ltd?
Zenotech Laboratories Ltd has a market capitalisation of ₹ 269 Cr as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Zenotech Laboratories Ltd?
Before investing in Zenotech Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.